Skip to content
Open access

Proteomic profiling of cortex and spinal cord in Tau-P301L transgenic cynomolgus macaques

Sep 2026 · Scientific Data · 0 citations

TL;DR

This Data Descriptor provides a reusable non-human primate proteomic resource for tissue-resolved analysis and comparison of tau-associated molecular features.

Abstract

Tau pathology is a defining feature of several neurodegenerative disorders, but reusable proteomic resources from non-human primate tauopathy models remain limited. Here we describe a four-dimensional label-free quantitative proteomic dataset from cortex and spinal cord tissues of wild-type and Tau-P301L transgenic cynomolgus macaques. The dataset comprises 16 neural tissue samples from four wild-type and four Tau-P301L animals, with paired cortical and spinal cord specimens collected from each monkey. Samples were analysed by LC-MS/MS on a Bruker timsTOF Pro platform, and label-free quantification was performed with MaxQuant against a Macaca fascicularis UniProt protein database. In total, 6,632 protein-group entries were identified, of which 6,520 protein groups were retained in the analysis-ready matrix for quality control and reuse. The accompanying records include raw mass spectrometry files, processed expression matrices, sample metadata and analysis scripts. This Data Descriptor provides a reusable non-human primate proteomic resource for tissue-resolved analysis and comparison of tau-associated molecular features.

Read PDF

Similar papers

Open access Sep 2026

Plasma and cerebrospinal fluid proteomics reveal distinct patterns of senescence and neuropathology in aging rhesus macaques.

Together, these results map compartment-specific signatures of senescence and early neuropathology across the non-human primate (NHP) lifespan and support the use of NHP models in translational biomarker studies.

Giovanne B. Diniz, Kayla Schwartz, Carissa T. Erices et al. · 0 citations
Open access Oct 2026

Brain region- and solubility-dependent proteomic signatures of neurofibrillary tangle pathology in Alzheimer’s disease

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer's disease. However, the molecular basis underlying their spatial heterogeneity and biochemical complexity remain unclear. To address this, we performed mass spectrometry-based proteomic profiling of two neocortical regions with different susceptibilities to NFT...

Xue-Mei Zeng, E. Abrahamson, W. G. Balogun et al. · 0 citations
Open access Oct 2026

Comparative neuropathological evaluation of pT217 immunoreactivity in human and transgenic mouse tauopathies.

Tau phosphorylation at threonine 217 (pT217) has been increasingly recognized as a biomarker for Alzheimer disease (AD), but its neuropathological distribution and the performance of available antibodies remain to be fully characterized. In this study, we performed a comparative evaluation of a recombinant rabbit monoc...

Emi Higashiizumi, Hiroshi Shimizu, Takaaki Nishikawa et al. · 0 citations
Open access Oct 2026

Endogenous APP-Associated Proteomics in Mouse Brain Defines a Candidate Resource for APP Trafficking and Proteostasis Studies

Background/Objectives: Affinity proteomics of amyloid precursor protein (APP) is complicated by proteolytic processing, dynamic trafficking, and purification background. We generated a C-terminal 3×FLAG knock-in at the endogenous App locus to establish a cortical affinity-proteomic resource and prioritize APP-associate...

Ye-Ting Zeng, Shu-Shan Wei, Ke-Yi Hu et al. · 0 citations
Open access Oct 2026

Tau isoform mapping across tissues and biofluids reveals a signature distinguishing Alzheimer’s disease from amyotrophic lateral sclerosis

Blood phosphorylated tau 217 (p-tau217) accurately detects Alzheimer’s disease (AD) pathology but is also elevated in amyotrophic lateral sclerosis (ALS), likely reflecting peripheral (big) tau released from muscle. Assays selectively measuring brain-derived (BD-) tau and BD-p-tau217 are therefore needed. We analysed s...

S. Abu-Rumeileh, H. Großkopf, Arthur Guthknecht et al. · 0 citations
Open access Sep 2026

Human P301L tau expression in mice alters neuronal excitability independent of neurodegeneration

Data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation.

K. Dunton, Hugo Monchal, Brie E Achorn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.